Overview
A clinical study testing an investigational once-weekly injectable medicine to reduce body weight and improve health in people with obesity or overweight who do not have type 2 diabetes. Participation lasts about 79 weeks.
Eligibility
18 or older; BMI 30+, or 27+ with a weight-related condition; do not have type 2 diabetes
Inclusion18 or older; BMI 30+, or 27+ with a weight-related condition; do not have type 2 diabetes
Location
Johns Hopkins University, Baltimore, MD
Study Flyer
